G. C. Giudice

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study

M. Tiseo, B. Vincenzi, S. Buti, 2023, Cancer Immunology, Immunotherapy.

Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression.

E. Giovannetti, M. Tiseo, A. Leonetti, 2021, European journal of cancer.

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

U. Maestroni, S. Buti, F. Perrone, 2023, Technology in cancer research & treatment.

Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.

S. Buti, M. Santoni, E. Silini, 2023, Frontiers in bioscience.

Vaccine approaches to treat urothelial cancer

G. C. Giudice, G. Sonpavde, 2024, Human vaccines & immunotherapeutics.

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

M. Brunelli, S. Buti, U. de Giorgi, 2023, Expert review of anticancer therapy.